Chilean Biotechnology Company Gets Major Distribution Agreement With Bayer

December, 2016 - Santiago, Chile

Three young Chilean biotechnologists managed to draw the attention of the German pharmaceutical giant Bayer Health Animal with its Milkeeper S product, which prevents or eradicates bacteria in animals and has been successfully used in the bovine industry.

Phage Technologies is a Chilean biotechnology company founded in 2009 by the Biotech engineers, Hans Pieringer, Diego Belmar and Nicolás Ferreira. The company has been incubated in the Science and Life Foundation of Dr. Pablo Valenzuela and supported by its Business Director, Cristián Hernández-Cuevas.

The negotiation of the distribution contract between Bayer and Phage Technologies lasted more than a year. During this time, the Chilean company was subjected to intense tests and controls run by Bayer, in order to certify the quality of its product. Advised by Carey’s partners Guillermo Carey, Cristián Eyzaguirre and Francisco Guzmán, Phage reached this important global distribution agreement, which is already being recognized as a successful case in the current Venture Capital ecosystem in Chile.

Phage creates biotechnologies to add new functions to animal and human food, developing solutions for important industry and production problems.

dots